MangoRx vs Maximus: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: MangoRx scores higher on our rubric, 7.5/10 against 5.1/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit MangoRx - our pick of these two →or find your match

MangoRx beats Maximus overall, scoring 7.5/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; Maximus is published $79.99/mo; total not verified. Choose MangoRx for needle-phobic users who want oral-only glp-1 tablets from a publicly traded company. Choose Maximus for men who want glp-1 alongside testosterone or other men's health protocols.

A side-by-side look at MangoRx and Maximus to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

MangoRx

#22 of 54

7.5/10

Multi-service telehealth platform offering compounded GLP-1 alongside other health services.

Visit MangoRx

Maximus

#50 of 54

5.1/10

Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.

Visit Maximus

Feature	MangoRx	Maximus
Why each one	Oral dissolving tablets exclusively (zero injections) from a publicly traded company (NASDAQ: MGRX) with SEC-level financial transparency.	Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market.
Our Score	7.5/10	5.1/10
Headline Price	from $299/mo	published $79.99/mo; total not verified
Medication Type	Compounded	Compounded
Insurance Accepted	No	No
Best For	Needle-phobic users who want oral-only GLP-1 tablets from a publicly traded company	Men who want GLP-1 alongside testosterone or other men's health protocols
Watch out for	Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.	The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
Ranking	#22	#50
Get started	Visit MangoRx	Visit Maximus

Pros & Cons Compared

MangoRx

Pros

+Oral dissolving tablets exclusively, zero injections for any GLP-1 option
+Publicly traded on NASDAQ (MGRX), SEC-required financial transparency that private competitors can't match
+Semaglutide tablet includes Vitamin B6 to help reduce nausea during treatment
+Free 100% online consultation with no video call required

Cons

−Oral semaglutide at $299/mo runs 2-3x injectable alternatives ($99-149/mo). The premium only makes sense if needles are a hard no for you.
−Early-stage public company with limited revenue; the same SEC filings that provide transparency also show the financial uncertainty reflected in the stock.
−Oral tablets are the only format, with no injectable option if you want higher bioavailability. If you may switch to injections later, pick a platform that carries both.

Maximus

Pros

+Lowest published microdose medication price we track, $79.99/mo semaglutide; consultation and lab fees are separate
+GLP-1 microdosing available for BMI as low as 22, the only platform serving patients below standard obesity criteria
+Maximus markets a semaglutide formula with added glycine and B12 as a way to ease nausea; we found no Maximus-specific clinical trial validating that claim
+Free expedited shipping on all medication orders

Cons

−The $99.99/mo rate is introductory: standard dosing is $299.99/mo, with consultations billed separately at $28-35 and labs at $199-349/yr, so budget on the standard rate, not the intro
−Compounding pharmacy partners are not disclosed, a transparency gap for a healthcare platform
−Bulk-plan prices rise as your dose escalates; ask for the full dose-price schedule up front so total cost isn't a surprise
−FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding

Our Verdict

MangoRx edges out Maximus with a score of 7.5/10 vs 5.1/10. Published pricing is not a like-for-like monthly comparison: MangoRx is from $299/mo; Maximus is published $79.99/mo; total not verified.